New track-and-trace proposal advanced to combat drug counterfeiting, gray market

Published on November 1, 2012 at 5:10 AM · No Comments

Politico Pro reports on a draft legislative proposal released last week.

Politico Pro: Track And Trace Draft Could Address Drug Counterfeiting
The bipartisan track and trace draft legislation released last week would allow drugs to be authenticated throughout the supply chain, which could help combat counterfeiting as well as the so-called gray market that's been highlighted in the drug shortage crisis, Democratic staffers who worked on the draft said. The legislation would initially establish only a lot -- or batch -- level drug pedigree requirement. But it requires every bottle of pills or vial of drugs contained in a lot to be labeled with a unique identifier of its own. That can be traced back to the manufacturer lot and confirmed as authentic (Norman, 10/30).

Meanwhile, CQ HealthBeat reports that another coalition, this one made up of HIV and AIDS advocates, is urging Congress to take a balanced approach to deficit reduction efforts that would not include the automatic cuts called for as a result of the sequester.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment